Tetrahydroberberine Suppresses Autophagy and Mitigates Doxorubicin‐Induced Ferroptosis in Hepatic Cells via cAMP ‐Epac1 Activation
Phytotherapy Research · 2026-11-02
DOI: 10.1002/ptr.70500 ↗At a glance
Journal article in Phytotherapy Research, published online on 2026-11-02. Written by Cheng Teng and 9 co-authors. Institution: Department of Anesthesiology, Zhejiang Cancer Hospital, Zhejiang, Hangzhou, China. 34 references. The full text is freely available (open access, CC BY 4.0). Funded by: Hangzhou Institute of Medicine, Chinese Academy of Sciences, the Zhejiang Provincial Medical and Health Science and Technology Program, the Zhejiang Cancer Hospital National Natural Science Foundation of Cultivation Fund Program.
Abstract (original language)
This study investigated the hepatoprotective mechanism of tetrahydroberberine (THB) against doxorubicin (DOX)‐induced liver injury. Using DOX‐induced drug‐induced liver injury (DILI) mouse models and AML12 hepatocytes, THB significantly reduced serum ALT/AST levels, alleviated hepatic pathological damage, and suppressed autophagic flux and ferroptosis. Mechanistically, THB activated the cAMP‐Epac1 axis by directly binding Epac1, stabilizing FTH1 and upregulating GPX4, thereby blocking the crosstalk between ferritinophagy and ferroptosis. Network pharmacology suggested the cAMP pathway, and experimental validation identified Epac1 as the functional target. These mechanisms were validated using ESI‐09, rapamycin, 3‐MA, CETSA, and molecular docking. This study is the first to elucidate THB's hepatoprotective mechanism via the cAMP‐Epac1/FTH1/GPX4 pathway, offering a natural product‐based strategy for chemotherapy‐associated liver injury.
Subjects
Author keywords
Authors and institutions
- Department of Anesthesiology, Zhejiang Cancer Hospital, Zhejiang, Hangzhou, China.
- Laboratory of Anesthesia and Perioperative Medicine, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Zhejiang, Hangzhou, China.
- Department of Physiology, Naval Medical University, Shanghai, China.
ORCID profiles: Mo Chen, Xiaoyan Zhu, Pengxiang Wang, Pingbo Xu
Funding
- Hangzhou Institute of Medicine, Chinese Academy of Sciences
- the Zhejiang Provincial Medical and Health Science and Technology Program
- the Zhejiang Cancer Hospital National Natural Science Foundation of Cultivation Fund Program
Cite
APA
Teng, C., Chen, M., Zhao, Y., Hu, S., Kong, L., Huang, Y., Cai, S., Zhu, X., Wang, P., & Xu, P. (2026). Tetrahydroberberine Suppresses Autophagy and Mitigates Doxorubicin‐Induced Ferroptosis in Hepatic Cells via cAMP ‐Epac1 Activation. Phytotherapy Research. https://doi.org/10.1002/ptr.70500
Vancouver
Teng C, Chen M, Zhao Y, Hu S, Kong L, Huang Y, et al. Tetrahydroberberine Suppresses Autophagy and Mitigates Doxorubicin‐Induced Ferroptosis in Hepatic Cells via cAMP ‐Epac1 Activation. Phytotherapy Research. 2026. doi:10.1002/ptr.70500
BibTeX
@article{Teng2026,
author = {Teng, Cheng and Chen, Mo and Zhao, Ying and Hu, Song and Kong, Linghui and Huang, Yan and Cai, Shunv and Zhu, Xiaoyan and Wang, Pengxiang and Xu, Pingbo},
title = {Tetrahydroberberine Suppresses Autophagy and Mitigates Doxorubicin‐Induced Ferroptosis in Hepatic Cells via cAMP ‐Epac1 Activation},
journal = {Phytotherapy Research},
year = {2026},
doi = {10.1002/ptr.70500}
}
EUVIMED